BC-006

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameBC-006
Drug Alias NameBC-006BC006ADG125ADG-125
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary FibrosisPulmonary Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAdagene Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesDragonboat Biopharmaceutical
Inactive CompaniesN/A
Active IndicationsSolid tumoursIdiopathic Pulmonary FibrosisPulmonary Fibrosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A